Relapse prevention interventions for smoking cessation
Updated review found that behavioural interventions provided no worthwhile benefit in preventing relapse in assisted abstainers. Moderate certainty evidence suggests that extended treatment with varenicline but not bupropion helped to prevent relapse. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 21, 2020 Category: Consumer Health News Source Type: news

Contrave Boosts Weight Loss in Diabetes Patients on Incretins Contrave Boosts Weight Loss in Diabetes Patients on Incretins
Naltrexone/bupropion added to a GLP-1 agonist or a DPP-4 inhibitor is a reasonable option for weight loss in patients with obesity and type 2 diabetes, a study suggests.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 30, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Antidepressant Fails to Improve Apathy in Dementia Patients Antidepressant Fails to Improve Apathy in Dementia Patients
The antidepressant bupropion was no better than placebo in reducing apathy in nondepressed patients with Alzheimer-type dementia in a randomized controlled trial.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - May 29, 2020 Category: Primary Care Tags: Psychiatry News Source Type: news

International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Pravastatin Sodium Tablets USP, 40mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-925-16; Lot # 115698A
International Laboratories, LLC is voluntarily recalling one (1) Lot of Pravastatin Sodium Tablets USP 40 mg packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Pravastatin Sodium Tablets USP 40 mg but contained Bupropion Hydrochloride XL 300 mg tablets. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 21, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Serotonin toxicity from isolated bupropion overdoses - Sidlak AM, Koivisto KO, Marino RT, Abesamis MG.
Background: Bupropion is a synthetic cathinone, which acts therapeutically through norepinephrine and dopamine reuptake inhibition. Recent evidence suggests that serotonin receptor activation occurs with high doses of bupropion and severe serotonin ... (Source: SafetyLit)
Source: SafetyLit - April 21, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Buproprion associated seizures following acute overdose: who develops late seizures - Offerman S, Gosen J, Thomas SH, Padilla-Jones A, Ruha AM, Levine M.
Objectives: Bupropion is an antidepressant that is commonly known to cause seizures in overdose. Because of concern for delayed onset of seizures, patients are frequently observed for prolonged periods after overdose. The primary objective is to eva... (Source: SafetyLit)
Source: SafetyLit - March 30, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Wellbutrin (bupropion)
Title: Wellbutrin (bupropion)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/12/2020 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - February 12, 2020 Category: Drugs & Pharmacology Source Type: news

Clinical characteristics and outcomes associated with bupropion overdose: a Canadian perspective - Stewart E, Grewal K, Hudson H, Thompson M, Godwin J.
Background: Therapeutic use, overdose and recreational abuse of bupropion are increasing. The purpose of this study was to describe the incidence and outcomes of bupropion exposures reported to the Ontario Poison Centre in Canada, and to identify pr... (Source: SafetyLit)
Source: SafetyLit - December 16, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Drug safety update: Naltrexone/bupropion (Mysimba)
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update that patients should be advised that naltrexone/bupropion has been associated with adverse reactions such (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 20, 2019 Category: Drugs & Pharmacology Source Type: news

Medical News Today: Everything you need to know about Wellbutrin for ADHD
Doctors sometimes prescribe Wellbutrin to treat ADHD if a person cannot take stimulants. Learn more about the efficacy and risks here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 20, 2019 Category: Consumer Health News Tags: ADHD / ADD Source Type: news

Toxicity of bupropion overdose compared with selective serotonin reuptake inhibitors - Overberg A, Morton S, Wagner E, Froberg B.
OBJECTIVES: Adolescent depression and attempted and completed suicide are increasing in the United States. Because suicide is often impulsive, the means of self-harm are frequently items of convenience like medication. Authors of a recent study compared tr... (Source: SafetyLit)
Source: SafetyLit - July 8, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Zoloft (sertraline) vs. Wellbutrin (bupropion)
Title: Zoloft (sertraline) vs. Wellbutrin (bupropion)Category: MedicationsCreated: 6/27/2019 12:00:00 AMLast Editorial Review: 6/27/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 27, 2019 Category: Drugs & Pharmacology Source Type: news

Methaemoglobinemia induced by poppers and bupropion intoxication in the emergency department - Batista F, Alves C, Trindade M, Duarte JA, Marques R.
A 40-year-old man presented to the emergency department with dyspnoea and fatigue after bupropion and popper consumption. Clinical examination was remarkable for central cyanosis not responding to supplementary oxygen. Arterial blood gas analysis showed a ... (Source: SafetyLit)
Source: SafetyLit - April 3, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

bupropion extended release (Forfivo XL)
Title: bupropion extended release (Forfivo XL)Category: MedicationsCreated: 10/16/2013 12:00:00 AMLast Editorial Review: 3/13/2019 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - March 13, 2019 Category: Psychiatry Source Type: news

Smoking During Pregnancy Doubles Risk Of Sudden Death For Baby, Study Says
(CNN) — Smoking even one cigarette a day during pregnancy can double the chance of sudden unexpected death for your baby, according to a new study analyzing over 20 million births, including over 19,000 unexpected infant deaths. The study, published Monday in the journal Pediatrics, analyzed data on smoking during pregnancy from the US Centers for Disease Control and Prevention’s birth/infant death data set between 2007 and 2011 and found that the risk of death rises by .07 for each additional cigarette smoked, up to 20 a day, a typical pack of cigarettes. By the time you smoke a pack a day, the study found, yo...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 11, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Cigarettes Pregnancy Smoking Source Type: news

Antidepressant shortage alarms Saskatchewan patients with mental illnesses
The shortage in Canada of bupropion, a popular prescription antidepressant, has been stressful for patients with mental illnesses and the people who care for them. (Source: CBC | Health)
Source: CBC | Health - November 18, 2018 Category: Consumer Health News Tags: News/Canada/Saskatchewan Source Type: news

Shortage of antidepressant 'in a class all on its own' alarms patients with mental illnesses
The shortage in Canada of bupropion, a popular prescription antidepressant, has been stressful for patients with mental illnesses and the people who care for them. (Source: CBC | Health)
Source: CBC | Health - November 18, 2018 Category: Consumer Health News Tags: News/Canada/Saskatchewan Source Type: news

Which Drugs Work Best for ADHD? Large Study Zeroes in on Two
The researchers compared seven ADHD drugs -- amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate and modafinil -- and a placebo over 12 weeks of treatment. (Source: WebMD Health)
Source: WebMD Health - August 8, 2018 Category: Consumer Health News Source Type: news

A Genetic Test Could Help Predict the Right Antidepressant For You
Depression is a complicated condition, and so are the people it affects. It’s often difficult — and can take months or even years — to find the right drugs to treat the heterogeneous mood disorder. But for decades, doctors have been treating depression essentially by prescribing a drug and hoping for the best. They rely on asking people about their family history of mental illness and fold in as much information as they can about symptoms. Since 2010, however, there has been a genetic test that can help doctors learn how a person’s genetic makeup can also affect their response to various antidepress...
Source: TIME: Health - May 7, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Brain Depression healthy time Source Type: news

No Heart Risk From Stop-Smoking Drugs Chantix and Zyban: Study
Title: No Heart Risk From Stop-Smoking Drugs Chantix and Zyban: StudyCategory: Health NewsCreated: 4/10/2018 12:00:00 AMLast Editorial Review: 4/11/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - April 11, 2018 Category: Cardiology Source Type: news

Study: Stop-smoking drugs Chantix, Zyban pose no heart risks
New research shows the stop-smoking drugs Chantix and Zyban are as safe for the heart as nicotine patches and dummy pills. (Source: ABC News: Health)
Source: ABC News: Health - April 9, 2018 Category: Consumer Health News Tags: Health Source Type: news

Rapid Bupropion-induced Hepatotoxicity Rapid Bupropion-induced Hepatotoxicity
This case demonstrates the rare, but potentially serious possibility of idiosyncratic bupropion-induced hepatotoxicity.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 23, 2018 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

La FDA revisa la descripci ón de los efectos secundarios para la salud mental de los medicamentos para dejar de fumar Chantix (vareniclina) y Zyban (bupropión) para reflejar las conclusiones de estudio clínico
FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 8, 2018 Category: Drugs & Pharmacology Source Type: news

La FDA revisa la descripci ó n de los efectos secundarios para la salud mental de los medicamentos para dejar de fumar Chantix (vareniclina) y Zyban (bupropi ó n) para reflejar las conclusiones de estudio cl í nico
FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 8, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Drug Safety Communication: FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings
An FDA review found the side effects on mood, behavior, or thinking with the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) are lower than previously suspected. These risks still exist, but we believe the benefits of quitting smoking outweigh them. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 8, 2018 Category: Drugs & Pharmacology Source Type: news

Cymbalta vs. Wellbutrin Comparison
Title: Cymbalta vs. Wellbutrin ComparisonCategory: MedicationsCreated: 12/12/2017 12:00:00 AMLast Editorial Review: 12/12/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 12, 2017 Category: Drugs & Pharmacology Source Type: news

bupropion (Wellbutrin, Wellbutrin SR, Wellbutrin XL, Zyban, Aplenzin, Fortivo XL, Zyban)
Title: bupropion (Wellbutrin, Wellbutrin SR, Wellbutrin XL, Zyban, Aplenzin, Fortivo XL, Zyban)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/7/2017 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - November 7, 2017 Category: Psychiatry Source Type: news

Lexapro vs. Wellbutrin: Differences between Side Effects and Uses
Title: Lexapro vs. Wellbutrin: Differences between Side Effects and UsesCategory: MedicationsCreated: 11/2/2017 12:00:00 AMLast Editorial Review: 11/2/2017 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - November 2, 2017 Category: Psychiatry Source Type: news

Suicidal bupropion ingestions in adolescents: increased morbidity compared with other antidepressants - Sheridan DC, Lin A, Zane Horowitz B.
The objective of this study was to compare outcomes in adolescent su... (Source: SafetyLit)
Source: SafetyLit - September 30, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Pravastatin Recalled Over Bupropion Mix-Up (FREE)
By the Editors One lot of pravastatin tablets (40 mg, 30-tablet bottles) manufactured by International Laboratories, LLC has … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 14, 2017 Category: Primary Care Source Type: news

International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Pravastatin Sodium Tablets USP, 40mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-925-16; Lot # 115698A
International Laboratories, LLC is voluntarily recalling one (1) Lot of Pravastatin Sodium Tablets USP 40 mg packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Pravastatin Sodium Tablets USP 40 mg but contained Bupropion Hydrochloride XL 300 mg tablets. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 10, 2017 Category: Food Science Source Type: news

For Treatment-Resistant Depression, Add an Antipsychotic or Switch Antidepressants? (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM For patients with depression unresponsive to antidepressants, adding the antipsychotic aripiprazole seems modestly better than switching to the antidepressant bupropion, a JAMA study … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - July 12, 2017 Category: Primary Care Source Type: news

Study compares switching meds vs. an additional med for patients unresponsive to an antidepressant
(The JAMA Network Journals) Among patients unresponsive to an antidepressant medication, adding the antipsychotic aripiprazole modestly increased the likelihood of remission from depression compared to switching to the antidepressant bupropion, according to a study published by JAMA. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 11, 2017 Category: International Medicine & Public Health Source Type: news

Jubilant Life Sciences gets USFDA nod for anti-depressive drug
The approved product is the generic version of Wellbutrin XL of Valeant, which is used for the treatment of major depressive disorder and prevention of seasonal affective disorder. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 6, 2017 Category: Pharmaceuticals Source Type: news

Cocaine abuse, traumatic brain injury, and preexisting brain lesions as risk factors for bupropion-associated psychosis - Barman R, Kumar S, Pagadala B, Detweiler MB.
BACKGROUND AND OBJECTIVE: Bupropion is generally considered safe and is widely used both as a monotherapy and as an augmentation agent for the treatment of major depression. Concerns have been raised about bupropion's propensity to precipitate new psychosi... (Source: SafetyLit)
Source: SafetyLit - June 9, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Navamedic ASA for Mysimba(R) (naltrexone HCl / bupropion HCl prolonged release) in Five Nordic Countries
SAN DIEGO, May 2, 2017 -- (Healthcare Sales & Marketing Network) -- Orexigen Therapeutics, Inc. (NASDAQ: OREX) today announced that its wholly owned subsidiary, Orexigen Therapeutics Ireland Ltd., and Navamedic AB, an affiliate of Navamedic ASA (Oslo:NAVA... Biopharmaceuticals, Distribution Orexigen Therapeutics, Navamedic AB, Mysimba, naltrexone, bupropion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 2, 2017 Category: Pharmaceuticals Source Type: news

Budeprion XL (Bupropion Hydrochloride Extended-Release Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 8, 2017 Category: Drugs & Pharmacology Source Type: news

Smoking-Cessation Meds, Counseling Work in Patients With CVD Smoking-Cessation Meds, Counseling Work in Patients With CVD
In contrast with some earlier research, a meta-analysis found that varenicline and bupropion along with counseling by phone or in person all seem effective in patients with cardiovascular disease.Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 24, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Aplenzin (Bupropion Hydrobromide Tablet) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

Contrave (Naltrexone HCl and Bupropion HCl Extended-Release Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

La FDA revisa la descripci ó n de los efectos secundarios para la salud mental de los medicamentos para dejar de fumar Chantix (vareniclina) y Zyban (bupropi ó n) para reflejar las conclusiones de estudio cl í nico
FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 5, 2017 Category: Drugs & Pharmacology Source Type: news

La FDA revisa la descripci ón de los efectos secundarios para la salud mental de los medicamentos para dejar de fumar Chantix (vareniclina) y Zyban (bupropión) para reflejar las conclusiones de estudio clínico
FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 5, 2017 Category: Drugs & Pharmacology Source Type: news

Black Box Warnings Removed From Chantix, Zyban
(Source: WebMD Health)
Source: WebMD Health - December 19, 2016 Category: Consumer Health News Source Type: news

Health Highlights: Dec. 19, 2016
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Black Box Warnings Removed From Chantix and Zyban The anti-smoking drug Chantix no longer has to carry a bold-letter warning about possible... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 19, 2016 Category: Journals (General) Source Type: news

FDA Drug Safety Communication: FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings
An FDA review found the side effects on mood, behavior, or thinking with the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) are lower than previously suspected. These risks still exist, but we believe the benefits of quitting smoking outweigh them. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 16, 2016 Category: Drugs & Pharmacology Source Type: news

Chantix, Zyban Lose Boxed Warning on Psych Effects
(MedPage Today) -- Labels will still note serious neuropsychiatric risk but without the black box (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 16, 2016 Category: American Health Source Type: news

How to Quit Smoking
By Stacy Simon Tobacco use remains the single largest preventable cause of disease and premature death in the United States. Since the release of the Surgeon General’s Report on Smoking and Health 50 years ago, there have been 20 million deaths due to tobacco. Almost half the deaths from 12 different types of cancer combined – including lung, voice box, throat, esophagus, and bladder cancers – are attributable to cigarette smoking alone. In addition to cancer, smoking greatly increases the risk of debilitating long-term lung diseases like emphysema and chronic bronchitis. It also raises the risk for heart...
Source: American Cancer Society :: News and Features - November 16, 2016 Category: Cancer & Oncology Tags: Smoking/Tobacco Source Type: news

Wellbutrin XL (Bupropion Hydrochloride Extended-Release) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 14, 2016 Category: Drugs & Pharmacology Source Type: news